Congress Large Cap Growth ETF (CAML)
Live price chart, market sentiment, and community perspectives for Congress Large Cap Growth ETF (AMEX: CAML).
Live price chart, market sentiment, and community perspectives for Congress Large Cap Growth ETF (AMEX: CAML).
On our desk, we are closely tracking CAML's recent technical signals. With near and mid-term sentiment holding strong and no resistance levels remaining above the current price, the technical setup points toward compelling upside potential. However, we remain cautious about the broader macro headwinds, including tariff uncertainty and slowing global PMIs, which could easily cap gains if growth sentiment shifts abruptly.
Looking at the quantitative risk metrics, CAML presents a mixed picture. The fund carries a beta of 1.13 and a portfolio risk score of 79, which Morningstar rates as Very Aggressive. At the same time, its 3-year, 5-year, and 10-year risk vs. category ratings are logged as Low, yet this lower risk profile has not translated into superior peer-relative returns. We are watching the Sharpe ratio of 0.37 closely before committing fresh capital.
Our short interest analysis shows that as of July 31, 2026, CAML had 26,189 shares sold short, representing about 0.28% of the public float. This marks a 21.99% increase from the prior month, bringing the days to cover to roughly 1.1 days based on average daily volume of 28,966 shares. While short interest remains a small fraction of the float, the uptick indicates growing tactical hedging or bearish positioning against the fund.
When evaluating the fund's investment process, we appreciate Congress Asset Management's bottom-up strategy targeting established profitability, positive free cash flow, and prudent debt management. However, from a portfolio management standpoint, the trailing P/E of roughly 35x and portfolio P/S of 6.68x represent a clear premium over both the category average of 24.95x and the comparison index, leaving virtually no margin of safety if earnings disappoint.
From a macro allocation perspective, CAML's reliance on long-duration growth assets sits against a backdrop where the Federal Reserve has held rates between 4.25% and 4.50%. While modest easing later in 2026 could offer support, the fund's modest AUM of $372.06 million and daily dollar volume around $696K create real trading friction for institutional rebalancing and retail execution alike.
Explore plasma cleansing, somatic organ swaps, and BCI.